Send feedback

MYO7B p.Glu1330Lys

c.3988G>A · rs372033406 · VCV3166289

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.0844 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0121%, afr)
Missense predictors
1/3 damaging
AlphaMissense, REVEL, SaProt

Computational evidence

Protein change
AlphaMissense0.0844likely benign
REVEL0.119moderately benign-leaning
SaProtLLR -10.55damaging
⇒ SaProt calls this damaging; AlphaMissense and REVEL do not.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 0.095GERP -3.2, phastCons 0.001
Regional constrainto/e 0.94unconstrained · MANE · 69 kb · p 0.0075 · regional, not allelic
Overall
CADD7.411PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM E1304K vs ClinVar E1330K) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0121% African / African-American · 9/74,586 alleles
Filtering AF 0.00626% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00469%
Overall 0.00395% 63/1,595,082 alleles · ultra-rare exomes 54/1,442,758 · genomes 9/152,324 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0259% 3,866
African / African-Americangrpmax 0.0121% 8,287
Admixed American 0.00689% 14,517
South Asian 0.00686% 14,573
Ashkenazi Jewishnot grpmax-eligible 0.00343% 29,142
East Asian 0.00228% 43,842
European (non-Finnish) 0.00222% 45,061

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MYO7B
Protein
p.Glu1330Lys
Coding
c.3988G>A
MANE Select
NM_001393586
dbSNP
rs372033406
Type
single nucleotide variant
Location
chr2:127624261 (GRCh38)
Gene constraint
LOEUF 0.956 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 78.34 · 3 PDB
Residue 1304 UniProt numbering
the 'mediates interaction with anks4b' region; the ferm 1 domain
Full MYO7B gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/myo7b-p-glu1330lys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown